MedDay completes patient enrolment in Phase III trial

PARIS: MedDay Pharmaceuticals has completed patient enrolment in the SPI2 Phase III clinical trial evaluating

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In